Gemzar and haemoglobin decreased Patient Reports February 13, 2012

Gemzar Side Effects Report #4991158-4
Gemzar side effect was reported by a Physician from GERMANY on Apr 20, 2006. Male patient, 56 years of age, weighting 143.3 lb, was diagnosed with transitional cell carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: c-reactive protein increased, haemoglobin decreased, nausea

, pyrexia. Gemzar dosage: 1400 MG, INTRAVENOUS. During the same period patient was treated with AREDIA. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5068924-2
Gemzar side effect was reported by a Physician from JAPAN on July 11, 2006. Female patient, 82 years of age, weighting 75.18 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acrodermatitis, bone marrow failure, carbohydrate antigen 19-9 increased, gastric ulcer, haemoglobin decreased, hypertension, malignant ascites, necrosis. Gemzar dosage: 500 MG INTRAVENOUS. During the same period patient was treated with DEPAS, ISOSORBIDE MONONITRATE, OMEPRAZOLE, ETODOLAC, MUCOSTA. Patient died on 06/29/2006.

Gemzar Side Effects Report #5874265-3
Gemzar side effect was reported by a Physician from JAPAN on Aug 25, 2008. Male patient, 76 years of age, weighting 123.5 lb, was diagnosed with pancreatic carcinoma stage iv, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutrophil count decreased, pneumonia cytomegaloviral. Gemzar dosage: 400 MG, WEEKLY (1/W). During the same period patient was treated with KYTRIL, DECADRON. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5566686-3
Gemzar side effect was reported by a Physician from JAPAN on Dec 13, 2007. Male patient, 75 years of age, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, jaundice

, jaundice cholestatic, liver disorder, malignant neoplasm progression, platelet count decreased, white blood cell count decreased. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4788769-8
Gemzar side effect was reported by a Physician from JAPAN on Sept 20, 2005. Female patient, 74 years of age, weighting 130.1 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain

, ascites, blood pressure decreased, c-reactive protein increased, decreased appetite, diarrhoea, haemoglobin decreased, hepatic neoplasm malignant, ileus. Gemzar dosage: 1000 MG OTHER. During the same period patient was treated with FAMOTIDINE, MARZULENE S, SOLITA T. Patient recovered.

Gemzar Side Effects Report #5197084-2
Gemzar side effect was reported by a Physician from JAPAN on Dec 20, 2006. Male patient, 73 years of age, weighting 109.8 lb, was diagnosed with pancreatic carcinoma stage iv, prophylaxis of nausea and vomiting and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bone marrow failure, chest x-ray abnormal, dyspnoea, haemoglobin decreased, hepatic enzyme increased, interstitial lung disease, platelet count decreased. Gemzar dosage: 1400 MG, OTHER. During the same period patient was treated with KYTRIL, DECADRON #. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5303237-2
Gemzar side effect was reported by a Physician from JAPAN on Apr 11, 2007. Male patient, 72 years of age, weighting 123.5 lb, was diagnosed with pancreatic carcinoma stage iv, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiac failure, dyspnoea, haemoglobin decreased, infection

, oedema, palpitations, pleural effusion. Gemzar dosage: 1500 MG, OTHER. During the same period patient was treated with WARFARIN POTASSIUM. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5318947-0
Gemzar side effect was reported by a Physician from JAPAN on May 01, 2007. Male patient, 68 years of age, weighting 103.8 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: ascites, gastrointestinal haemorrhage, haemoglobin decreased, malignant neoplasm progression, nephritis interstitial, renal failure acute. Gemzar dosage: 1400 MG, OTHER. During the same period patient was treated with GASTER, LOXONIN, SELBEX, LASIX. Patient died on 12/13/2002.

Gemzar Side Effects Report #4551258-X
Gemzar side effect was reported by a Health Professional from on Dec 21, 2004. Male patient, 64 years of age, weighting 147.7 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, haematoma, haemoglobin decreased, jaundice cholestatic, malignant neoplasm progression, pyrexia, venous thrombosis limb. Gemzar dosage: 1000MG/M2 OTHER. During the same period patient was treated with MS CONTIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5318946-9
Gemzar side effect was reported by a Physician from JAPAN on May 01, 2007. Male patient, 52 years of age, weighting 126.8 lb, was diagnosed with pancreatic carcinoma stage iv, diabetes mellitus and was treated with Gemzar. After drug was administered, patient experienced the following side effects: ascites, disease progression, haemoglobin decreased, nephritis interstitial, renal failure acute, small intestinal haemorrhage. Gemzar dosage: 1600 MG, OTHER. During the same period patient was treated with GLIBENCLAMIDE. Patient died on 11/19/2002.

Gemzar Side Effects Report #5606551-6
Gemzar side effect was reported by a Physician from JAPAN on Jan 16, 2008. Male patient, weighting 132.3 lb, was diagnosed with pancreatic carcinoma stage iv, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, malnutrition, renal disorder, white blood cell count decreased. Gemzar dosage: 1600 MG, OTHER. During the same period patient was treated with DECADRON, KYTRIL, NEUTROGIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5638149-8
Gemzar side effect was reported by a Physician from JAPAN on Feb 14, 2008. Male patient, weighting 132.3 lb, was diagnosed with pancreatic carcinoma stage iv, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, malnutrition, renal disorder, white blood cell count decreased. Gemzar dosage: 1600 MG, OTHER. During the same period patient was treated with DECADRON, KYTRIL, NEUTROGIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5892552-X
Gemzar side effect was reported by a Physician from JAPAN on Sept 12, 2008. Male patient, weighting 141.1 lb, was diagnosed with pancreatic carcinoma stage iii and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, hyponatraemia, hypoproteinaemia, interstitial lung disease, oedema, pleural effusion, pleurisy. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with NAUZELIN, ADALAT CR, DIOVAN, RABEPRAZOLE, URSO, FOIPAN, TAURINE. Patient was hospitalized and became disabled. Patient recovered.

Gemzar Side Effects Report #5912452-6
Gemzar side effect was reported by a Physician from JAPAN on Sept 26, 2008. Male patient, weighting 141.1 lb, was diagnosed with pancreatic carcinoma stage iii and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, hyponatraemia, hypoproteinaemia, interstitial lung disease, oedema, pleural effusion, pleurisy. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with NAUZELIN, ADALAT CR, DIOVAN, RABEPRAZOLE, URSO, FOIPAN, TAURINE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #6115295-6
Gemzar side effect was reported by a Health Professional from UNITED STATES on Nov 06, 2008. Male patient, 69 years of age, was diagnosed with pancreatic carcinoma recurrent and was treated with Gemzar. After drug was administered, patient experienced the following side effects: fatigue, haemoglobin decreased, lung infiltration, malignant neoplasm progression, pyrexia. Gemzar dosage: unknown. During the same period patient was treated with TARCEVA, CREON, METOPROLOL TARTRATE, ZOCOR, METFORMIN, ZOFRAN, PROTONIX, COLACE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5418083-9
Gemzar side effect was reported by a Physician from JAPAN on Aug 08, 2007. Male patient, 68 years of age, was diagnosed with pancreatic carcinoma non-resectable and was treated with Gemzar. After drug was administered, patient experienced the following side effects: diabetes mellitus, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Gemzar dosage: 800 MG, OTHER. During the same period patient was treated with THERAPEUTIC RADIOPHARMACEUTICALS. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5290310-0
Gemzar side effect was reported by a Physician from FRANCE on Mar 28, 2007. Male patient, 57 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, diffuse alveolar damage, haemoglobin decreased, pulmonary oedema. Gemzar dosage: 1000 MG/M2, OTHER. During the same period patient was treated with GLYBURIDE, METFORMIN, LASIX. Patient was hospitalized. Patient died on 01/04/2007.

Gemzar Side Effects Report #5068050-2
Gemzar side effect was reported by a Physician from AUSTRALIA on July 10, 2006. Male patient, 83 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood sodium decreased, blood urea increased, haematocrit decreased, haemoglobin decreased, hypoxia, lung consolidation, lung infiltration, red blood cell count decreased. Gemzar dosage: 800 MG/M2, OTHER,. During the same period patient was treated with NOVOBAN, DECADRON, ISCOVER, SOTALOL, ASPIRIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4991159-6
Gemzar side effect was reported by a Health Professional from JAPAN on Apr 18, 2006. Male patient, 78 years of age, weighting 125.7 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, pneumonitis, white blood cell count decreased. Gemzar dosage: 1600 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5002811-0
Gemzar side effect was reported by a Physician from JAPAN on Apr 28, 2006. Male patient, 78 years of age, weighting 125.7 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: c-reactive protein increased, haemoglobin decreased, pneumonitis, pyrexia, white blood cell count decreased. Gemzar dosage: 1600 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5241727-1
Gemzar side effect was reported by a Physician from GERMANY on Feb 09, 2007. Female patient, 76 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood cholinesterase decreased, blood creatinine increased, haemoglobin decreased, malignant neoplasm progression, platelet count decreased, prothrombin time prolonged, transaminases increased. Gemzar dosage: 1000 MG/M2, UNK. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5521170-8
Gemzar side effect was reported by a Physician from JAPAN on Nov 07, 2007. Male patient, 75 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, jaundice

, jaundice cholestatic, liver disorder, malignant neoplasm progression, platelet count decreased, white blood cell count decreased. Gemzar dosage: unknown. Patient recovered.

Gemzar Side Effects Report #4638387-7
Gemzar side effect was reported by a Physician from on Mar 29, 2005. Male patient, 73 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: ascites, blood albumin decreased, haemoglobin decreased, platelet count decreased, pleural effusion. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4640694-9
Gemzar side effect was reported by a Physician from on Mar 29, 2005. Male patient, 73 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: ascites, blood albumin decreased, haemoglobin decreased, platelet count decreased, pleural effusion. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4662768-9
Gemzar side effect was reported by a Physician from on Apr 22, 2005. Male patient, 73 years of age, weighting 125.7 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood creatinine increased, c-reactive protein increased, capillary leak syndrome, haematocrit decreased, haemoglobin decreased. Gemzar dosage: 1600 MG OTHER. During the same period patient was treated with FOIPAN, BERIZYM, BIOFERMIN, SCOPOLIA, FAMOTIDINE, LOPERAMIDE, HALCION, NAIXAN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4724548-5
Gemzar side effect was reported by a Physician from GERMANY on July 01, 2005. Male patient, 73 years of age, weighting 158.7 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood sodium decreased, cardiac failure, congestive cardiomyopathy, dilatation ventricular, haemoglobin decreased, mitral valve incompetence, platelet count decreased, pleural effusion, ventricular hypokinesia. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with CLOPIDOGREL BISULPHATE, LISINOPRIL, INSULINE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4662767-7
Gemzar side effect was reported by a Physician from on Apr 20, 2005. Male patient, 72 years of age, weighting 114.6 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: catheter site haemorrhage, condition aggravated, disseminated intravascular coagulation, haemoglobin decreased, haemolytic anaemia, haemolytic uraemic syndrome, haemorrhagic diathesis, international normalised ratio increased, liver disorder. Gemzar dosage: 1400 MG OTHER. During the same period patient was treated with KYTRIL, DECADRON, SULPERAZON. Patient recovered.

Gemzar Side Effects Report #5485631-2
Gemzar side effect was reported by a Physician from JAPAN on Oct 01, 2007. Male patient, 68 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, diabetes mellitus, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Gemzar dosage: 800 MG, OTHER. During the same period patient was treated with THERAPEUTIC RADIOPHARMACEUTICALS. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5486380-7
Gemzar side effect was reported by a Physician from JAPAN on Oct 01, 2007. Male patient, 68 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: diabetes mellitus, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Gemzar dosage: 800 MG, OTHER. During the same period patient was treated with THERAPEUTIC RADIOPHARMACEUTICALS. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4613259-2
Gemzar side effect was reported by a Physician from on Mar 01, 2005. Male patient, 64 years of age, weighting 147.7 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, jaundice cholestatic, malignant neoplasm progression, oedema peripheral, pancreatic carcinoma, phlebothrombosis. Gemzar dosage: 1000 MG/M2 OTHER. During the same period patient was treated with MS CONTIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4546605-9
Gemzar side effect was reported by a Physician from on Dec 14, 2004. Female patient, 62 years of age, weighting 103.6 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, haemoglobin decreased, hepatic failure, malignant neoplasm progression, metastases to liver, neutrophil count decreased, white blood cell count decreased. Gemzar dosage: 210 MG OTHER. During the same period patient was treated with VOLTARENE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #6018221-3
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 17, 2008. Female patient, 59 years of age, was diagnosed with pancreatic carcinoma, postoperative care and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood magnesium decreased, blood potassium decreased, haemoglobin decreased, hernia

, neutrophil count, pyrexia, white blood cell count, white blood cell disorder. Gemzar dosage: 1800 MG, WEEKLY (1/W). During the same period patient was treated with GLIPIZIDE, METFORMIN, MAGNESIUM OXIDE, COUMADIN, ANTIHYPERTENSIVES, PANCREASE, HYDROCODONE BITARTRATE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5675289-1
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 19, 2007. Male patient, 57 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: depression

, haemoglobin decreased, hypertension. Gemzar dosage: unknown. Patient recovered.

Gemzar Side Effects Report #4578543-X
Gemzar side effect was reported by a Physician from on Jan 20, 2005. Female patient, 54 years of age, weighting 110.2 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory failure, blood lactate dehydrogenase increased, c-reactive protein increased, dyspnoea, haemoglobin decreased, interstitial lung disease, lung infiltration, pleural effusion. Gemzar dosage: 1500 MG OTHER. Patient recovered.

Gemzar Side Effects Report #5605905-1
Gemzar side effect was reported by a Physician from JAPAN on Jan 16, 2008. Male patient, weighting 138.9 lb, was diagnosed with pancreatic carcinoma, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood calcium decreased, cardiac failure congestive, haemoglobin decreased, neutrophil count decreased, oedema, pleural effusion, white blood cell count decreased. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with BERIZYM, GASMOTIN, URSO, GASTER D, LAC B, LEUCON, CEPHARANTHIN, NEUPOGEN. Patient recovered.

Gemzar Side Effects Report #5638165-6
Gemzar side effect was reported by a Physician from JAPAN on Feb 14, 2008. Male patient, weighting 138.9 lb, was diagnosed with pancreatic carcinoma, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood calcium decreased, cardiac failure congestive, haemoglobin decreased, neutrophil count decreased, white blood cell count decreased. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with BERIZYM, GASMOTIN, URSO, GASTER D, LAC B, LEUCON, CEPHARANTHIN, NEUPOGEN. Patient recovered.

Gemzar Side Effects Report #4714603-8
Gemzar side effect was reported by a Health Professional from UNITED STATES on July 14, 2005. Female patient, 74 years of age, weighting 145.5 lb, was diagnosed with ovarian cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: chills, feeling abnormal, haemoglobin decreased, neutropenia, platelet count decreased, pyrexia, white blood cell count decreased. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5759608-3
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on May 28, 2008. Female patient, weighting 109.0 lb, was diagnosed with ovarian cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, malignant neoplasm progression, multi-organ failure, ovarian cancer, respiratory failure, sepsis

, white blood cell count decreased. Gemzar dosage: 1000 MG/M2, UNK. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient died on 05/08/2008.

Gemzar Side Effects Report #5337434-7
Gemzar side effect was reported by a Physician from UNITED STATES on Sept 25, 2006. Female patient, 62 years of age, weighting 121.9 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, platelet count decreased, red blood cell count decreased, white blood cell count decreased. Gemzar dosage: 1000 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with CARBOPLATIN, PREDNISONE, PREVACID, PROCHLORPERAZINE MALEATE, TRAMADOL, PERSANTINE, PREGABALIN. Patient recovered.

Gemzar Side Effects Report #5087095-X
Gemzar side effect was reported by a Health Professional from TURKEY on Aug 01, 2006. Male patient, 61 years of age, weighting 154.3 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: bone marrow toxicity, dyspnoea, haemoglobin decreased, loss of consciousness, neutrophil percentage decreased, platelet count decreased, white blood cell count decreased. Gemzar dosage: 1800 MG, OTHER, INTRAVENOUS. During the same period patient was treated with CISPLATIN, ANTIEMETICS AND ANTINAUSEANTS, ANTIHISTAMINES, CORTICOSTEROIDS. Patient was hospitalized. Patient died on 03/11/2004.

Gemzar Side Effects Report #4822120-X
Gemzar side effect was reported by a Physician from JAPAN on Oct 13, 2005. Male patient, 82 years of age, weighting 83.78 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain

, anaemia, anxiety

, aortic aneurysm

, asthenia, cardio-respiratory arrest, decreased appetite, haemoglobin decreased, platelet count decreased. Gemzar dosage: 1000 MG OTHER. During the same period patient was treated with CARBOPLATIN, GASTER D, LASIX, ASPARA K, TOLEDOMIN. Patient died on 09/27/2005.

Gemzar Side Effects Report #5337810-2
Gemzar side effect was reported by a Physician from UNITED STATES on Jan 11, 2006. Male patient, 74 years of age, weighting 179.9 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, dyspnoea, haemoglobin decreased, platelet count decreased, platelet count increased, pulmonary toxicity, white blood cell count decreased, white blood cell count increased. Gemzar dosage: unknown. Patient recovered.

Gemzar Side Effects Report #4992605-4
Gemzar side effect was reported by a Health Professional from UNITED STATES on Jan 11, 2006. Male patient, 74 years of age, weighting 179.9 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, dyspnoea, haematocrit decreased, haemoglobin decreased, platelet count decreased, platelet count increased, pulmonary toxicity, white blood cell count decreased, white blood cell count increased. Gemzar dosage: 1800 MG. Patient recovered.

Gemzar Side Effects Report #6115275-0
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 29, 2008. Male patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood count abnormal, haemoglobin decreased, lacrimation increased, ocular hyperaemia, paraesthesia, platelet count decreased, vomiting, white blood cell count decreased. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with NEXIUM, ANTIHYPERTENSIVES. Patient recovered.

Gemzar Side Effects Report #4579432-7
Gemzar side effect was reported by a Physician from on Jan 24, 2005. Female patient, 69 years of age, weighting 191.8 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, platelet count decreased, pruritus, stridor, white blood cell count decreased. Gemzar dosage: 1600 MG. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5889534-0
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 09, 2008. Female patient, 60 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood pressure increased, convulsion, fatigue, fluid intake reduced, full blood count abnormal, haemoglobin decreased, laboratory test abnormal, malnutrition, nausea

. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN, AVASTIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4734995-3
Gemzar side effect was reported by a Pharmacist from UNITED STATES on July 15, 2005. Female patient, 43 years of age, weighting 200.6 lb, was diagnosed with metastatic neoplasm and was treated with Gemzar. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood chloride decreased, blood potassium decreased, crackles lung, dyspnoea, haematocrit decreased, haemoglobin decreased, hyperhidrosis. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with IRINOTECAN. Patient recovered.

Gemzar Side Effects Report #4680543-6
Gemzar side effect was reported by a Physician from on May 13, 2005. Male patient, 48 years of age, weighting 163.1 lb, was diagnosed with metastatic bronchial carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: asthenia, cough, crepitations, haemoglobin decreased, neutrophil count decreased, platelet count decreased, purpura, pyrexia, red blood cell count decreased. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN, DEPAKENE, URBANYL, IMUDON, NEURONTIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4957297-9
Gemzar side effect was reported by a Physician from UNITED STATES on Mar 14, 2006. Male patient, 62 years of age, weighting 190.0 lb, was diagnosed with mesothelioma

and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory failure, bronchitis acute, bronchopneumonia, diffuse alveolar damage, haemoglobin decreased, haemorrhage, interstitial lung disease, malignant neoplasm progression, pleural fibrosis. Gemzar dosage: 800 MG, INTRAVENOUS. During the same period patient was treated with ALIMTA, PROCRIT, ARANESP, RANITIDINE, DECADRON, VITAMIN B12, FOLIC ACID, BENADRYL. Patient died.

Gemzar Side Effects Report #4681906-5
Gemzar side effect was reported by a Physician from on May 13, 2005. Male patient, 70 years of age, weighting 185.2 lb, was diagnosed with malignant neoplasm of renal pelvis, transitional cell carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urea increased, cardiac failure congestive, dyspnoea, haemoglobin decreased, myocardial infarction, pulmonary oedema. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with CISPLATIN, CARBOPLATIN, VERGENTAN. Patient died on 04/21/2005.

Gemzar Side Effects Report #4611092-9
Gemzar side effect was reported by a Pharmacist from on Nov 08, 2004. Male patient, 79 years of age, weighting 187.4 lb, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: chills, dementia

, haemoglobin decreased, pyrexia, red blood cell count decreased, white blood cell count decreased. Gemzar dosage: 2060 MG. During the same period patient was treated with ASPIRIN, DILTIAZEM, LESCOL, ATROVENT, SAW PALMETTO, PRANDIN, SEREVENT. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4639984-5
Gemzar side effect was reported by a Physician from on Mar 30, 2005. Female patient, 79 years of age, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood albumin decreased, c-reactive protein increased, febrile neutropenia, gastrointestinal haemorrhage, haemoglobin decreased, thrombocytopenia, white blood cell agglutination present. Gemzar dosage: 1350 MG. During the same period patient was treated with CARBOPLATIN, THYROXINE, ZYRTEC, DETRUSITOL, ALBYL, ZOCOR. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4642054-3
Gemzar side effect was reported by a Physician from on Mar 30, 2005. Female patient, 79 years of age, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood albumin decreased, c-reactive protein increased, febrile neutropenia, gastric ulcer, gastrointestinal haemorrhage, haemoglobin decreased, thrombocytopenia, white blood cell agglutination present. Gemzar dosage: 1350 MG OTHER. During the same period patient was treated with CARBOPLATIN, THYROXINE, ZYRTEC, DETRUSITOL, ALBYL, ZOCOR. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4697522-5
Gemzar side effect was reported by a Health Professional from on June 02, 2005. Male patient, 63 years of age, weighting 167.6 lb, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase decreased, blood alkaline phosphatase increased, blood urea increased, haematocrit decreased, haemoglobin decreased, hypoacusis, white blood cell count increased. Gemzar dosage: 800 MG/M2/1 WEEK. During the same period patient was treated with AVASTIN, COUMADIN, DIGOXIN, FOLIC ACID, MS CONTIN, CELEBREX, LASIX, ZOLOFT. Patient recovered.

Gemzar Side Effects Report #5017114-8
Gemzar side effect was reported by a Health Professional from UNITED STATES on May 01, 2006. Female patient, 74 years of age, weighting 110.0 lb, was diagnosed with lung cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: asthenia, atrial tachycardia, haematocrit decreased, haemoglobin decreased, sepsis

, ventricular tachycardia. Gemzar dosage: 1430 MG OTHER INTRAVENOUS. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5033869-0
Gemzar side effect was reported by a Health Professional from UNITED STATES on June 07, 2006. Female patient, 74 years of age, weighting 110.0 lb, was diagnosed with lung cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: asthenia, atrial tachycardia, haematocrit decreased, haemoglobin decreased, sepsis

, ventricular tachycardia. Gemzar dosage: 1430 MG, OTHER, INTRAVENOUS. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4703843-X
Gemzar side effect was reported by a Health Professional from on June 10, 2005. Male patient, 63 years of age, weighting 167.6 lb, was diagnosed with lung cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood urea increased, deafness, haematocrit decreased, haemoglobin decreased, white blood cell count increased. Gemzar dosage: 800 MG/M2/1 WEEK. During the same period patient was treated with AVASTIN, COUMADIN, DIGOXIN, FOLIC ACID, MS CONTIN, CELEBREX, LASIX, ZOLOFT. Patient recovered.

Gemzar Side Effects Report #5293008-8
Gemzar side effect was reported by a Physician from JAPAN on Apr 04, 2007. Female patient, 66 years of age, weighting 120.8 lb, was diagnosed with lung adenocarcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: bladder disorder, cystitis, haemoglobin decreased, recall phenomenon, thrombosis, urinary retention. Gemzar dosage: 1500 MG, UNK. During the same period patient was treated with CODEINE PHOSPHATE, AZULFIDINE EN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5186327-7
Gemzar side effect was reported by a Physician from JAPAN on Nov 14, 2006. Male patient, 68 years of age, weighting 132.3 lb, was diagnosed with lung adenocarcinoma stage iii and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, interstitial lung disease, lymphangiosis carcinomatosa. Gemzar dosage: 1000 MG/M2, OTHER. During the same period patient was treated with MAGNESIUM OXIDE, PURSENNID, MARZULENE S, LOXONIN, PARIET, MYSLEE, ISODINE, CYANOCOBALAMIN. Patient died on 10/08/2006.

Gemzar Side Effects Report #4546650-3
Gemzar side effect was reported by a Physician from on Dec 16, 2004. Male patient, 60 years of age, weighting 165.3 lb, was diagnosed with lung adenocarcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: adenocarcinoma, bone marrow depression, haemoglobin decreased, malignant neoplasm progression, nausea

, pain

, thrombocytopenia, white blood cell count increased. Gemzar dosage: 2410 MG/2 OTHER. During the same period patient was treated with CARBOPLATIN, MORPHINE, LANSOPRAZOLE, CORDARONE, FLUCONAZOLE. Patient was hospitalized. Patient died on 11/14/2004.

Gemzar Side Effects Report #5597428-3
Gemzar side effect was reported by a Physician from JAPAN on Jan 11, 2008. Male patient, weighting 143.5 lb, was diagnosed with large cell lung cancer stage iv, pain

, red blood cell count decreased. Gemzar dosage: 1400 MG, OTHER. During the same period patient was treated with CISPLATIN, VOLTAREN, LENDORMIN, GASTER D, LOXONIN, NORVASC. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5660808-1
Gemzar side effect was reported by a Physician from JAPAN on Feb 28, 2008. Male patient, weighting 143.5 lb, was diagnosed with large cell lung cancer stage iv, pain

and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, lymphadenopathy, lymphocyte count decreased, malignant neoplasm progression, metastases to peritoneum, pneumocystis jiroveci pneumonia, red blood cell count decreased, renal impairment. Gemzar dosage: 1400 MG, OTHER. During the same period patient was treated with CISPLATIN, VOLTAREN, LENDORMIN, GASTER D, LOXONIN, NORVASC. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5520491-2
Gemzar side effect was reported by a Physician from JAPAN on Nov 06, 2007. Female patient, weighting 106.9 lb, was diagnosed with gallbladder cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood albumin decreased, haemoglobin decreased, hepatic function abnormal, malignant neoplasm progression, neutrophil count decreased, platelet count decreased, po2 decreased, white blood cell count decreased. Gemzar dosage: 1400 MG, OTHER. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5604534-3
Gemzar side effect was reported by a Physician from JAPAN on Jan 16, 2008. Female patient, weighting 101.4 lb, was diagnosed with gallbladder cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anorexia, blood creatinine increased, dehydration, haemoglobin decreased, hyponatraemia, nausea

, neutrophil count decreased. Gemzar dosage: 1000 MG/M2, OTHER. During the same period patient was treated with CISPLATIN, EVISTA, NORVASK, LIPITOR, METOCLOPRAMIDE, KYTRIL, DECADRON #, DECADRON #. Patient was hospitalized. Patient died.

Gemzar Side Effects Report #5371734-X
Gemzar side effect was reported by a Physician from JAPAN on June 18, 2007. Male patient, 81 years of age, weighting 85.98 lb, was diagnosed with gallbladder cancer recurrent and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, interstitial lung disease, platelet count decreased. Gemzar dosage: 1000 MG/M2, UNK. During the same period patient was treated with HARNAL, SENNOSIDE A, LEUCON. Patient was hospitalized. Patient died on 06/13/2007.

Gemzar Side Effects Report #5507828-5
Gemzar side effect was reported by a Physician from JAPAN on Oct 26, 2007. Female patient was diagnosed with gallbladder cancer

and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, anastomotic ulcer, aortic valve incompetence, back pain

, cardiac failure, haemoglobin decreased, haemoptysis, hypertension, malaise. Gemzar dosage: unknown. During the same period patient was treated with LEUCON. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5728819-5
Gemzar side effect was reported by a Physician from JAPAN on Apr 28, 2008. Female patient, weighting 121.3 lb, was diagnosed with gallbladder cancer

and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, haemoglobin decreased, malignant neoplasm progression. Gemzar dosage: 1400 MG, OTHER. Patient died on 03/27/2008.

Gemzar Side Effects Report #6114612-0
Gemzar side effect was reported by a Physician from UNITED STATES on Mar 05, 2008. Female patient, 36 years of age, weighting 164.9 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, pulmonary toxicity. Gemzar dosage: 800 MG/M2 OTHER UNK. During the same period patient was treated with NAVELBINE, DOXIL. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5800232-1
Gemzar side effect was reported by a Physician from UNITED STATES on June 20, 2008. Female patient was diagnosed with breast neoplasm and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, haemolysis. Gemzar dosage: 1800 MG/M2, UNK. Patient recovered.

Gemzar Side Effects Report #4709563-X
Gemzar side effect was reported by a Health Professional from UNITED STATES on June 17, 2005. Female patient, 57 years of age, weighting 176.4 lb, was diagnosed with breast cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, alopecia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood glucose increased, epistaxis, haematocrit decreased, haemoglobin decreased, malignant neoplasm progression. Gemzar dosage: unknown. During the same period patient was treated with HERCEPTIN. Patient recovered.

Gemzar Side Effects Report #4959096-0
Gemzar side effect was reported by a Health Professional from UNITED STATES on Mar 13, 2006. Female patient, 54 years of age, weighting 192.7 lb, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, convulsion, dyspnoea, haematocrit decreased, haemoglobin decreased, neuropathy peripheral, pleural effusion, tremor. Gemzar dosage: unknown. During the same period patient was treated with TAXOTERE, ZOLOFT, PRILOSEC, CALCIUM WITH VITAMIN D, GLUCOSAMINE, ATIVAN, VITAMIN B. Patient recovered.

Gemzar Side Effects Report #4552687-0
Gemzar side effect was reported by a Physician from on Dec 28, 2004. Female patient, 47 years of age, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: diffuse alveolar damage, haemoglobin decreased, neutropenia. Gemzar dosage: 800 MG/M2 OTHER. During the same period patient was treated with TAXOTERE, HERCEPTIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4832721-0
Gemzar side effect was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on Nov 03, 2005. Female patient, 61 years of age, weighting 116.8 lb, was diagnosed with breast cancer

and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anorexia, blood alkaline phosphatase increased, haemoglobin decreased, lung neoplasm, nausea

, productive cough, upper respiratory tract infection. Gemzar dosage: 1500 MG/1 OTHER. During the same period patient was treated with GRANISETRON, CODEINE, AMBROXOL, MEGESTROL. Patient recovered.

Gemzar Side Effects Report #5360651-7
Gemzar side effect was reported by a Physician from UNITED STATES on June 11, 2007. Male patient, 68 years of age, was diagnosed with bladder cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: atelectasis, cryptogenic organising pneumonia, febrile neutropenia, haemoglobin decreased, haemoptysis, pleural effusion, sputum discoloured. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4992594-2
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 18, 2005. Male patient, child 10 years of age, was diagnosed with bladder cancer

and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cellulitis

, haematuria, haemoglobin decreased. Gemzar dosage: unknown. Patient recovered.

Gemzar Side Effects Report #6027094-4
Gemzar side effect was reported by a Physician from JAPAN on Dec 25, 2008. Male patient, weighting 138.2 lb, was diagnosed with bile duct cancer stage i, hypertension, hyperlipidaemia, prophylaxis, constipation

and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, platelet count decreased, pyrexia, retinal haemorrhage, white blood cell count decreased. Gemzar dosage: 1000 MG, UNK. During the same period patient was treated with DIOVAN, ARTIST, MEVALOTIN, ASPIRIN, ALOSITOL, MAGNESIUM OXIDE, PURSENNID. Patient recovered.

Gemzar Side Effects Report #5469368-1
Gemzar side effect was reported by a Physician from JAPAN on Sept 14, 2007. Female patient, 53 years of age, was diagnosed with bile duct cancer recurrent and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutrophil count increased, platelet count increased, red blood cell count decreased. Gemzar dosage: 1200 MG, OTHER. Patient recovered.

Gemzar Side Effects Report #5557953-8
Gemzar side effect was reported by a Physician from JAPAN on Dec 04, 2007. Female patient, 74 years of age, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, hyponatraemia, neutrophil count decreased. Gemzar dosage: 1000 MG/M2, OTHER. During the same period patient was treated with CISPLATIN. Patient recovered.

Gemzar Side Effects Report #4608773-X
Gemzar side effect was reported by a Physician from on Mar 01, 2005. Female patient, 62 years of age, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, condition aggravated, gamma-glutamyltransferase increased, haemoglobin decreased, haemolysis. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with METRONIDAZOLE, CIPROFLOXACIN, DUROGESIC. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5092012-2
Gemzar side effect was reported by a Physician from JAPAN on Aug 10, 2006. Male patient, 56 years of age, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, platelet count increased, white blood cell count decreased. Gemzar dosage: 1000 MG/M2, UNK, INTRAVENOUS. Patient recovered.

Gemzar Side Effects Report #5129136-7
Gemzar side effect was reported by a Physician from JAPAN on Sept 21, 2006. Male patient, 56 years of age, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, platelet count increased. Gemzar dosage: 1000 MG/M2, INTRAVENOUS. Patient recovered.

Gemzar Side Effects Report #5731701-0
Gemzar side effect was reported by a Physician from JAPAN on May 01, 2008. Male patient, weighting 145.5 lb, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: erythema, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Gemzar dosage: 1600 MG, UNK. During the same period patient was treated with DEPAKENE, CALONAL, LOXONIN, ALDACTONE, LANSOPRAZOLE, URSO, TAURINE. Patient died on 03/24/2008.

Gemzar Side Effects Report #5743886-0
Gemzar side effect was reported by a Physician from JAPAN on May 09, 2008. Male patient, weighting 159.8 lb, was diagnosed with bile duct cancer, constipation

, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cholangitis acute, haemoglobin decreased, interstitial lung disease, platelet count decreased. Gemzar dosage: 1700 MG, OTHER. During the same period patient was treated with MAGMITT, URSO. Patient was hospitalized. Patient died on 04/08/2008.

Gemzar Side Effects Report #5869757-7
Gemzar side effect was reported by a Physician from JAPAN on Aug 20, 2008. Male patient, weighting 145.5 lb, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: erythema, haemoglobin decreased, malignant neoplasm progression, oedema peripheral, platelet count decreased, white blood cell count decreased. Gemzar dosage: 1600 MG, UNK. During the same period patient was treated with DEPAKENE, ACETAMINOPHEN, LOXONIN, ALDACTONE, LANSOPRAZOLE, URSO, TAURINE. Patient died on 03/24/2008.

Gemzar Side Effects Report #4692394-7
Gemzar side effect was reported by a Physician from on May 30, 2005. Male patient, 39 years of age, weighting 136.7 lb, was diagnosed with adenocarcinoma, bronchial carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood urea decreased, haemoglobin decreased, local reaction, platelet count increased, skin test positive, toxic skin eruption. Gemzar dosage: 1250MG/M2/2 OTHER. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4992785-0
Gemzar side effect was reported by a Physician from UNITED STATES on May 31, 2005. Male patient, 77 years of age, was treated with Gemzar. After drug was administered, patient experienced the following side effects: dehydration, haematocrit decreased, haemoglobin decreased. Gemzar dosage: unknown. During the same period patient was treated with INFLIXIMAB, ALPHAGAN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4648941-4
Gemzar side effect was reported by a Health Professional from on Apr 12, 2005. Male patient, 62 years of age, was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, haemoglobin decreased, pain in extremity. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN, LIPITOR, PROCRIT. Patient recovered.

Gemzar Side Effects Report #4681602-4
Gemzar side effect was reported by a Health Professional from on May 11, 2005. Male patient, 62 years of age, was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, haemoglobin decreased, pain in extremity. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN, LIPITOR, PROCRIT. Patient recovered.

Gemzar Side Effects Report #4824518-2
Gemzar side effect was reported by a Physician from UNITED KINGDOM on Oct 27, 2005. Male patient, 62 years of age, was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, platelet count decreased. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient recovered.

Gemzar Side Effects Report #5383232-8
Gemzar side effect was reported by a Physician from JAPAN on June 28, 2007. Male patient, 61 years of age, weighting 108.0 lb, was diagnosed with prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: altered state of consciousness, blood pressure decreased, bone marrow failure, c-reactive protein increased, chest x-ray abnormal, febrile neutropenia, haemoglobin decreased, metastases to central nervous system, platelet count decreased. Gemzar dosage: 1200 MG, OTHER. During the same period patient was treated with CISPLATIN, ZOFRAN, DEXART. Patient was hospitalized and became disabled. Patient recovered.

Gemzar Side Effects Report #5422517-3
Gemzar side effect was reported by a Physician from JAPAN on Aug 09, 2007. Male patient, 61 years of age, weighting 108.0 lb, was diagnosed with prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: altered state of consciousness, blood pressure decreased, c-reactive protein increased, chest x-ray abnormal, febrile neutropenia, haemoglobin decreased, lung infiltration, metastases to central nervous system, platelet count decreased. Gemzar dosage: 1200 MG, OTHER. During the same period patient was treated with CISPLATIN, ZOFRAN, DEXART. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5499357-2
Gemzar side effect was reported by a Physician from JAPAN on Oct 17, 2007. Male patient, weighting 121.3 lb, was diagnosed with insomnia, constipation

and was treated with Gemzar. After drug was administered, patient experienced the following side effects: aortic valve incompetence, benign prostatic hyperplasia, cataract

, dyspnoea, haemoglobin decreased, pericardial effusion, pyrexia, rash

, renal failure. Gemzar dosage: 1200 MG, OTHER. During the same period patient was treated with LENDORMIN, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5588463-X
Gemzar side effect was reported by a Physician from JAPAN on Dec 28, 2007. Male patient, weighting 121.3 lb, was diagnosed with insomnia, constipation

and was treated with Gemzar. After drug was administered, patient experienced the following side effects: benign prostatic hyperplasia, cataract

, dyspnoea, haemoglobin decreased, pericardial effusion, pyrexia, rash

, renal failure, urticaria. Gemzar dosage: 1200 MG, OTHER. During the same period patient was treated with LENDORMIN, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.

Gemzar and haemoglobin decreased

SideEffects101.com

Gemzar and haemoglobin decreased Patient Reports February 13, 2012

side effects of Gemzar